In the Clinic
Rapid Stroke Diagnosis Saves Lives
When Emergency Medical Services (EMS) arrive on the scene, they are mandated to deliver the patient to the nearest hospital which is often not equipped to perform advanced stroke treatments like endovascular therapy.
Endovascular treatment within 2 hours of Large Vessel Occlusion (LVO) stroke onset has been shown to yield a 90% chance of good outcome.
Unfortunately, meta-analysis of endovascular therapy clinical trials have found that >55% of LVO stroke patients suffered poor outcomes of death or severe disability. This highlights the fact that even with the best treatment, without faster stroke routing we cannot improve outcomes in stroke care.
Our vision is to equip EMS with better neural diagnostics that could detect stroke sooner to more quickly route patients for definitive endovascular intervention in order to save lives and prevent disability.
We are also collaborating on therapeutics for Glioblastoma and other cancers, a range of mental diseases, and neurodegenerative diseases like Alzheimer's.
We are currently conducting clinical studies for clinical depression therapy and acute care settings with stroke and neurocritical care patients in collaboration with leading research institutions.
Openwater is open to partnership with leading academic centers for advancing the future of neural diagnostics.
Please email us:
Openwater has begun discussions with the FDA regarding the regulatory pathway for our initial technologies currently in human studies
An Example: Prehospital stroke detection with Openwater's technology could have significant clinical benefit in improving time to life-saving treatment. Health outcomes analysis estimates the impact of such a system on the US Healthcare system to result in $1.25 Billion annual savings.